Skip to content

Clinical trials

Completed Phase 3 Conjunctivitis, Allergic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Conjunctivitis, Allergic Phase: Phase 3 Status: Completed Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20053
20064
20076
20081
20094
20105
20125
20133
20143
20151
20184
20192
20211
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bausch & Lomb Incorporated9
Vistakon Pharmaceuticals9
Alcon Research7
Allergan4
Aciex Therapeutics, Inc.3
Aldeyra Therapeutics, Inc.3
Astellas Pharma Inc2
Faes Farma, S.A.2
Regeneron Pharmaceuticals2
Santen Pharmaceutical Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Conjunctivitis, Allergic51
Rhinitis, Allergic, Seasonal4
Hypersensitivity3
Conjunctivitis2
Keratoconjunctivitis2
Rhinitis, Allergic2
Nasal Obstruction1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.